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Does TCDD Exposure Alter β7-Integrin Expression on Mouse B Cells? 
Sebastian Ramos 
Mentor: Gregory DeKrey, Ph.D., Biological Sciences 
 
Abstract: Activated aryl hydrocarbon receptor with ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters 
immune responses, including immunoglobulin A (IgA). Manipulation of antibody production via this ligand-
activated receptor may provide a novel approach to enhance vaccination in the intestines. The present study aimed 
to explain the mechanism responsible for increased levels of fecal IgA in TCDD-treated mice. We hypothesized 
that TCDD enhances migration of B cells from non-intestinal tissue to the intestines. Here we predicted that β7-
integrin, an essential protein for B cell migration into the intestines, would be upregulated by TCDD exposure on 
B cells. Female C57BL/6 mice were treated with a single dose of peanut oil (control) or TCDD at 40 µg/kg by 
gavage. After 1 week, splenic leukocytes were isolated and analyzed by flow cytometry. B cells in TCDD-treated 
mice did not express significantly higher β7-integrin levels than controls, although a significant increase of β7 
integrin expression was observed on T cells. These results do not support our hypothesis; yet suggest that elevated 
β7 integrin expression allowed for preferential migration of B cells out of the spleen and into the intestines before 
analysis. In the future, we plan to address this possibility by examining β7 expression on B cells in the intestines. 
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Mucosal immunity plays an important role 
against pathogens and allergies. During mucosal 
infections, B cells go through a differentiation 
process that allows them to produce antibodies 
with high specificity and affinity for the infectious 
agents. IgA is one of five types of antibodies 
produced by B cells and it is found mainly in 
mucosal tissues such as the digestive tract, genital 
tract, and respiratory tract. IgA is linked to 
regulating commensal microbes in the gut, the 
risk of developing allergies, and defenses against 
pathogens and toxins (Cerutti, 2008). In the last 
three decades, studies on the aryl hydrocarbon 
receptor (AhR) have demonstrated altered B cell 
function in animals exposed to AhR-activating 
chemicals. However, limited research has focused 
on how AhR activation can affect IgA-expressing 
B cells. That is the focus of this study. 
The significance of the broader work is 
directed in hopes to manipulate humoral 
responses, such as IgA secretion in mucosal 
membranes, via this ligand-induced AhR to 
potentially develop vaccines containing 
compounds that could maximize the isotype 
presence in areas of the body. Manipulation of 
antibody production may be the novel approach to 
prevent diseases that occur through vocal and 
nasal airways, lining of the rectus, or genital  
 
ducts, including but not limited to HIV (Su, 
2014). 
Significance of IgA 
IgA acts as the first line of defense against 
pathogens at mucosal membranes in the body of 
mammals and is the most abundant antibody 
produced (Cerutti, 2008). B cells secrete IgA at 
mucosal membranes throughout the body to 
protect humans against food-, water-, and airborne 
pathogens because the gut and respiratory tract are 
the major point of contact with toxins and 
pathogens (Mantis, Rol, & Corthesy, 2011). In the 
intestines, this particular antibody is mostly 
produced by B cells in the lamina propria and 
secreted into the lumen of the intestines where it 
can also regulate gut microbiota populations and 
influence our risk of developing allergies (Wood, 
2006).  
Sufficient production of IgA is essential for 
protection against some mucosal-transmitted 
microbes; evidence indicates that increased 
specific IgA antibody production protects the 
body against Helicobacter pylori infection and 
suggests that lower levels of IgA allow pathogens 
such as H. pylori to colonize the gut with ease 
(Srivastava et al., 2013).  In a study aiming to 
demonstrate the importance of IgA in mucosal 
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membranes of the gut, Uren et.al. (2005) found 
that pathogens such as Vibrio cholerae and 
influenza virus, localized mainly in the mucosal 
areas of the body, seemed to affect body weight 
and health recovery in IgA knockout mice more 
negatively than those that had IgA-secreting B 
cells. Data suggests that the increment of IgA 
levels by immunization can prevent infections in 
local mucosal areas. For instance, high levels of 
fecal anti-cholera toxin B IgA in mice due to 
immunization prevented weight loss and lesser 
symptoms than those that did not show high levels 
of fecal IgA from lack of immunization (Price et 
al., 2013).  
The role that IgA plays against the human 
immunodeficiency virus (HIV) needs further 
studying, but sparse research shows the 
proprieties of IgA as a mucosal barrier. In a study 
done by Su and Moog (2014), IgA levels 
increased in HIV- people who interacted with 
HIV+ patients, especially in saliva and the genital 
tract. The implications of this can lead to the 
formation of protective ways to prevent infection 
against HIV. However, mechanisms are yet 
poorly understood. 
AhR-Mediated Biology  
The AhR is a ligand-dependent transcription 
factor that is known to regulate the expression of 
genes important for immune function, 
metabolism, cellular homeostasis, and others 
(Nebert, Puga, & Vasiliou, 1993). The AhR is 
found in most nucleated cells of vertebrates, 
including mammals (Okey, 2007). For 30 years, 
this receptor has been associated with mediating 
chemical toxicity and environmental contaminants 
(Stevens, Mezrich, & Bradfield, 2009). In the last 
decade, longstanding toxicology studies on 2,3,7,8 
tetrachlorodibenzo-p-dioxin (TCDD) have 
demonstrated an additional role for this protein in 
immunology (Stevens, Mezrich, & Bradfield, 
2009). 
2,3,7,8 Tetrachlorodibenzo-p-dioxin  
A number of different endogenous and 
exogenous ligands are known to activate the AhR, 
specifically polycyclic aromatic hydrocarbons 
(PAHs) (Denison & Nagy, 2003). However, 
TCDD has demonstrated to have the highest 
binding affinity out of all compounds related to 
AhR and a longer half-life (7-10 days) 
(Stejskalova et al., 2011). Much of our 
understanding regarding this receptor has been 
gleaned from the use of TCDD as it serves as a 
model to understand the effects of AhR in the 
immune system.  
TCDD is a toxic halogenated aromatic 
hydrocarbon that forms as a by-product or 
contaminant of materials such as 2, 4, 5-
trichlorophenol (TCP) which is used as an 
herbicide (Hay, 1979). The properties of TCDD 
limit its risks to direct contact because it is not 
volatile. The average U.S. resident has 
measureable levels of TCDD in their blood (up to 
30 parts per trillion) that come from common 
foods sold in U.S. markets (Schecter et. al., 2001); 
no study has shown that this level of TCDD 
causes adverse effects in humans. However, high 
TCDD levels (over 1000-fold) in the skin clearly 
lead to adverse health conditions such as 
chloracne (a severe form of acne; Forrester et. al., 
2014). Indication that intermediate levels of 
TCDD can cause disease in humans is less 
convincing because of its weak exposure-effect 
relationship. Due to the toxicity of TCDD, 
evidence that suggests changes in immune 
function in humans is scarce and poorly 
understood. Yet, there is ample and extensive 
evidence that TCDD exposure alters immune 
function, developmental abnormalities, metabolic 
disorders, and increases risk of tumor growth in 
mice (Baccarelli et al., 2004). In addition to 
altering the immune responses, lymphocytes seem 
to be particularly sensitive to TCDD exposure 
fluctuating their response against pathogens 
(Lawrence & Vorderstrasse, 2013). TCDD can 
dysregulate B cell differentiation, which causes 
suppression of antibody secretion in mice 
(Sulentic, Holsapple, & Kaminski, 1998).  
AhR-Dependent Immune Function  
In regards to immunology, the AhR is a 
ligand-dependent transcription factor that 
regulates the development and function of the 
innate and adaptive immune systems in various 
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ways (Zhou, 2016). Activation of the AhR has the 
ability to mediate immunological responses 
against pathogens with some responses being 
suppressed while others augmented. Suppressed 
immunity is related to the reduced ability to 
appropriately defend against diseases or respond 
to vaccination. Augmented immunity is related to 
enhanced inflammatory responses or 
dysregulation of self-tolerance mechanisms. For 
example, one study showed that numerous 
cytokines, including IL-6, IL-12, and TNF-α 
levels, were reduced upon activation of the AhR, 
though fecal IgA levels were increased (Benson & 
Shepherd, 2010). Low cytokine levels reduce 
inflammation and allows animals to recover 
faster. Studies like this are significant to our goal 
because animals treated with TCDD showed 
markedly reduced severity of autoimmune disease 
such as Cronh’s disease, a chronic gastrointestinal 
inflammation.  
This ligand-mediated activation is most potent 
in leukocytes comprising the adaptive immune 
system, meaning that a series of signaling 
pathways coordinate changes in the responses of 
several adaptive leukocytes (Sulentic, Holsapple, 
& Kaminski, 1998). Among the most widely 
reported impacts of AhR activation is suppression 
of IgM and IgG antibody levels (Vorderstrasse et 
al., 2003). However, the influence of activated 
AhR on IgA antibody levels is not very well 
understood.  
Studies on humans and laboratory animals 
suggest that exposure to AhR-activating 
compounds can alter IgA levels in blood and 
feces. For instance, a study done on 200 
adolescents in Belgium showed that lifetime 
exposure to TCDD increased IgA levels in serum 
(Van Den Heuvel et al., 2002). Oral exposure in 
mice with TCDD suppressed recruitment of CD8+ 
lymphocytes to the lungs, including decreased 
levels of interleukin-12 and decreased antibody 
production in the lungs. In addition to those 
findings, there was a four-fold increase of IgA in 
plasma after TCDD exposure in C57BL/6 mice 
(Warren et al., 2000). Similar to those findings, 
TCDD exposure affected the transport of IgA to 
the liver, which showed an increase of serum IgA 
(Moran et al., 1986). Studies by Ishikawa (2009) 
and Kinoshita et al. (2006) found decreased fecal 
IgA levels in rodents within the first 3 weeks after 
exposure, which suggests a reduced resistance to 
food- or water-borne pathogens and toxins. 
Limitations from the previously mentioned studies 
indicate that circadian rhythm, TCDD dosage, 
time, concentration and incubation time, and type 
of species, may alter the results.  
A handful of studies have looked at the effects 
of antibody levels upon treatment with TCDD. 
However, a clear consensus understanding 
regarding the mechanisms underlying AhR 
regulation of IgA production by B cells has yet to 
be achieved. Some of these previously mentioned 
studies suggested that the increased or decreased 
levels of IgA in serum or feces is not due to 
increased/reduced antibody production by B cells, 
but rather the presence/absence of B cells in the 
tissue. 
AhR-Mediated B Cell Migration  
Migration of lymphocytes, such as B cells, to 
the intestinal mucosa requires dimerization of β7 
with α4 integrin. A study in 2007, demonstrated 
the proposed idea of AhR-mediated migration in 
macrophages by exposure of PAHs. PAHs up-
regulated β7-integrin expression up to 6-fold 
factor at mRNA level among other α and β 
subunits in both human and mouse primary 
macrophages (Monteiro et al., 2007). AhR 
involvement was analyzed by using an antagonist 
of AhR, which prevented the upregulation of β7-
integrin in mRNA levels (Monteiro et al., 2007). 
These data suggest that TCDD (also an AhR 
agonist) may have the same effects on β7-integrin 
in B cells, which may lead to an increase rate of 
migration into the intestines. 
The AhR acts as one of the body’s 
environmental detector by binding to a wide 
variety of artificial and natural compounds found 
in our food. It is important to further understand 
the implications that the AhR has in our bodies, 
specifically in how our immune system responds 
to disease. If we can manipulate humoral 
responses, such as IgA secretion in mucosal 
membranes, via this ligand-induced receptor, we 
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can potentially develop vaccines containing 
compounds that could maximize the isotype 
presence in areas of the body. Manipulation of 
antibody production may be the novel approach to 
prevent diseases that occur at mucosal barriers 
such as oral and nasal airways, lining of the rectus 
or genital ducts, including but not limited to HIV 
(Su, 2014). 
A previous study in our laboratory has shown 
increased levels in fecal IgA upon activation of 
the AhR with TCDD exposure in mice (Metten & 
DeKrey, 2015). Based on existing literature and 
these findings, the purpose of the present study is 
to explain the increased levels of fecal IgA after 
exposure with TCDD in mice. We hypothesize 
that TCDD exposure enhances migration of B 
cells from non-intestinal tissue to the lamina 
propria of the intestines. If this hypothesis is 
supported, we will expect to find an increase in 
β7-integrin expression on splenic B cells. In the 
present study, we 1) enumerated total number of 
leukocytes in the spleen and 2) compared levels of 
β7-integrin expression on B cells and T cells with 




Female C57BL/6 mice, 6-8 weeks of age, 
were obtained from a breeding colony at the 
University of Northern Colorado animal facility. 
Animals were randomly assigned to one of two 
treatment groups and housed on a 12-hour 
day/night light cycle. The University of Northern 
Colorado Animal Care and Use Committee 
approved all protocols for the use of animals in 
keeping with current NIH guidelines for animal 
usage. Across two replicates, a total of twelve 
mice were used, with three mice in each treatment 
group (vehicle-treated controls and TCDD-treated 
at 40µg/kg) per experiment. 
Procedure 
Treatment  
TCDD was obtained from AccuStandard, Inc. 
(Haven, CT). TCDD was dissolved in a vehicle 
solution of peanut oil. Vehicle-treated mice 
(control) were only given peanut oil vehicle by 
gavage. The TCDD-treated group at 40µg/kg 
were given a single dose by gavage. After TCDD 
exposure, mice were observed every morning for 
1 week to ensure their health.  
Cell Preparation  
Mice were euthanized via CO2 asphyxiation 
from 10 a.m. to 11 a.m. Each spleen was removed 
and placed in medium containing DMEM + 1mM 
HEPES + 5% heat-inactivated FBS. Cells were 
liberated from the spleen by rubbing the tissues 
between the frosted ends of microscope slides. 
Cells were transferred from the cell suspension 
into centrifuge tubes and sedimented at 1300 rpm 
for 5 min. Supernatant was discarded and cells 
were re-suspended in the same medium. 
Erythrocytes were lysed by a 10 second exposure 
to water. The remaining cells (leukocytes) were 
stained with trypan blue and enumerated under a 
microscope using a hemocytometer. 
Flow Cytometry  
β7-integrin levels on B cells and T cells were 
determined using flow cytometry technique. The 
following antibodies were used to stain cells: 
Fluorescein-isothiocyanate (FITC)-conjugated 
anti-mouse β7-integrin (clone 11-44-2) or IgG1 
isotype control (clone KLH/G1-2-2); Alexa Fluor 
647 (AF647)-conjugated anti-mouse CD19 (clone 
RA3-6B2), -conjugated anti-mouse CD3 (clone 
RA3-6B2), or IgG1 isotype control (clone RA3-
6B2). Antibodies were purchased from Southern 
Biotech (Birminghan, AL) or BD PharMingen 
(San Jose, CA). Cells were analyzed on a BD 
Accuri C6 flow cytometer (San Jose, CA). A 
minimum of 18,000 cumulative events were 
collected per sample. A cell was considered 
positive (+) for expression of a marker if its 
fluorescence was greater than the fluorescence of 
the corresponding non-stained or isotype control-
stained cell population. Lymphocytes (based on 
90° light scatter versus FSC gating) were 
considered viable if they were negative for 7-
AAD fluorescence. Only single cells (based on 
integrated versus peak FSC) were considered for 
analysis.   
Statistical Analysis  
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The data were analyzed by two-way analysis 
of variance (ANOVA) and SigmaPlot statistical 
software. Sources of variation (effects) for the 
statistical model included the experiment number 
and the dose of TCDD. All-pairwise post-hoc t-
tests were used to determine differences between 
means. Each experiment was replicated a 
minimum of two times to ensure consistency of 
results. Values of p ≤ 0.05 were considered 
significant. 
RESULTS 
Statistical analysis was only based on TCDD 
source of variation and not on experiment nor 
experiment x TCDD interaction because the 
differences in mean values were not significant. In 
control mice, body weight ranged between 17-21 
g and was not significantly changed in 
comparison to the TCDD-treated group. 
Thymuses were observed to be smaller in TCDD-
treated mice (as reported by Metten & DeKrey, 
2015), and was considered a positive indicator of 
TCDD exposure. When compared to controls, the 
total number of splenic leukocytes in TCDD-
treated mice was significantly reduced (F(1,8) = 
12.254, p = 0.008). In contrast, the percentages of 
B cells and T cells in spleens were not altered by 
TCDD exposure with approximately 60% being B 
cells and 40% being T cells (see fig. 2A).  The 
percentage of CD3+ or CD19+ cells expressing 
β7-integrin was not significantly different 
between control and TCDD-treated mice.  The 
mean fluorescence for β7-integrin on CD19+ cells 
was not significantly different between control 
and TCDD-treated groups.  The mean 
fluorescence for β7-integrin on CD3+ TCDD-
treated cells, however, showed a significant 
increase in comparison to control (F(1,8) = 6.998, 
p = 0.029).  
Figure 1. Total number of splenic leukocyte at both 0 
and 40 ug/kg of TCDD. After isolation of splenic 
leukocytes, cells were counted using hemocytometers. 
Viability was shown by using trypan blue. Data are the 
means ± SD of two combined trials; they are shown 
comparatively to the value of β7-integrin levels found 
in control cells.  *p < 0.05. 
 
Figure 2. (A) Total percentage of CD19+ and CD3+ 
cells in the spleens at both zero, and 40 µg/Kg TCDD. 
(B) Mean fluorescence of FL1 depicts the mean 
expression of β7-integrin on both CD19+ and CD3+ at 
both 0 and 40 µg/Kg of TCDD. Splenic leukocytes 
were stained with AF647 (FL4) for anti-CD19 and 
anti-CD3 cells and FITC (FL1) for anti-β7-integrin. 
Β7-integrin levels were then analyzed using flow 
cytometry. Data are the means ± SD of two combined 
trials; they are shown comparatively to the value of 
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In the present study, we were unable to 
demonstrate that TCDD exposure enhances B 
cells migration by increasing β7-integrin 
expression on B cells. These results suggest that 
elevation of fecal IgA levels in TCDD-treated 
mice may be caused by a different mechanism. On 
the other hand, data showed significantly  
increased average β7-integrin expression on CD3+ 
cells from TCDD-treated mice indicating that 
TCDD exposure does impact β7-integrin 
expression on some cells. Interestingly, TCDD 
exposure significantly reduced total leukocyte 
numbers in spleens. Although a direct explanation 
for this change in leukocyte numbers is not 
provided by the results of this study, one 
possibility is that TCDD exposure on day 0 
caused an increase of β7-integrin expression on B 
cells (and other cells) which allowed for B cell 
migration to the intestines prior to analysis on day 
7. This particular information suggests that 
leukocytes did migrate out of the spleen into other 
tissues. We cannot say with certainty that these 
cells migrated into the intestines, but future 
studies may demonstrate so by directing their 
focus to collecting the spleens at different times or 
analyzing intestinal tissue instead. A high percent 
of interest should be placed by future researchers 
into understanding the effects of circadian rhythm 
on antibody levels if we wish to understand the 
implications of the AhR on IgA. The circadian 
rhythm has demonstrated to have an effect on 
antibody levels, which could aid in the 
understanding of B cell migration (Garrett & 
Gasiewicz, 2006). Our data suggest that B cells 
may have already migrated to the intestines or 
other tissues and that is why we did not obtain 
high levels of β7-integrin expression.  
The unchanged percentage of CD19+ and 
CD3+ cells across control and treated groups (fig 
2A) may suggest that there was no B cell 
migration at all. However, readers should see this 
figure as an indicator of the body’s effort toward 
achieving homeostasis as it encounters xenobiotic 
compounds like TCDD. The figure does not 
account for migration because it is only showing 
percentages and not total numbers. The total 
number may change without necessarily yielding 
a different ratio.  
Some limitations of the study include: (a) the 
time at which spleens were collected may have 
been a time when B cells had already migrated 
into the intestines; (b) the number of trials 
performed does not rule out the probability of 
random results; (c) we did not find a well-known 
range of β7-integrin levels in the literature for us 
to know how much was necessary to create a 
migration response; and (d) after we finished 
collecting our data, we received an email from BD 
that some of the antibodies we had purchased 
were being recalled for not working. In addition to 
that, TCDD and mice acting as models to study 
the AhR can be very valuable to understanding 
mechanisms and its effects in humans. However, 
it is necessary to understand the differences 
between mice and humans in regards to the AhR 
pathways, which are acknowledged by the authors 
but were not be investigated in this study. 
The AhR acts as the body’s environmental 
detector by binding to a wide variety of artificial 
and natural compounds found in places such as 
our own grocery stores. It is important to further 
understand the implications that the AhR has in 
our bodies, specifically in how our immune 
system responds to disease. More studies must be 
done to understand the mechanisms behind the 
AhR and IgA. Topics that are important to take 
into consideration for future studies are 
consolidating the period of time that takes TCDD 
B 
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to cause effects in the body, the time of collection 
due to changes in antibody levels affected by the 
circadian rhythm of mice, and the usage of 
different ligands to exert different responses in 
mouse models. Our study takes the first steps 
towards understanding the mechanisms behind 
AhR-mediated migration of B cells into the 
intestines. AhR activation shows to be capable of 
mediating the migration of splenic leukocyte to 
other tissues of the body, which can explain 
altered levels of antibodies in the intestines such 
as IgA. However, more research must be done in 
order to accurately show the mechanism for 
increased levels of fecal IgA. 
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